Literature DB >> 7927678

Murine tissues exposed to cytotoxic drugs display altered patterns of Candida albicans adhesion.

J L López-Ribot1, C S McVay, W L Chaffin.   

Abstract

An ex vivo adhesion assay was used to examine the binding of Candida albicans yeast cells to tissues from mice treated with cytotoxic drugs such as lipopolysaccharide and the clinically used anticancer drugs doxorubicin, cisplatin, and vincristine. No major differences were observed in binding of the fungal cells to liver and kidney tissues from treated or untreated animals. All drug-treated spleens displayed altered patterns of C. albicans adhesion compared with the control group, with yeast cells bound not only to the marginal zone but also to the white and red pulp. Immunostaining for macrophages, which are proposed as the site of normal adhesion, showed no apparent differences between the control and the experimental spleens that could account for the change in adhesion patterns. Scanning electron microscopy images suggested that yeast binding to the white pulp of treated tissue is mediated through fibers, perhaps extracellular matrix components exposed as result of the cytotoxic treatment. Exposure of new attachment sites for C. albicans in treated tissues may facilitate initiation of infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927678      PMCID: PMC303099          DOI: 10.1128/iai.62.10.4226-4232.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Risk factors for candidemia in cancer patients: a case-control study.

Authors:  A Karabinis; C Hill; B Leclercq; C Tancrède; D Baume; A Andremont
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

2.  Effects of cisplatin and two novel palladium complexes on Candida albicans.

Authors:  N M Moussa; M A Ghannoum; P A Whittaker; M S el-Ezaby; S Quraman
Journal:  Microbios       Date:  1990

3.  Modulation of endotoxin lethality in mice by hydrazine sulfate.

Authors:  R Silverstein; C A Christoffersen; D C Morrison
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

4.  Laminin receptors on Candida albicans germ tubes.

Authors:  J P Bouchara; G Tronchin; V Annaix; R Robert; J M Senet
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

5.  Characteristics of Candida albicans adherence to mouse tissues.

Authors:  J E Cutler; D L Brawner; K C Hazen; M A Jutila
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Adherence of Candida albicans to components of the subendothelial extracellular matrix.

Authors:  S A Klotz
Journal:  FEMS Microbiol Lett       Date:  1990-03-15       Impact factor: 2.742

7.  Endothelial cell contraction increases Candida adherence to exposed extracellular matrix.

Authors:  S A Klotz; R D Maca
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

8.  Binding of the extracellular matrix component entactin to Candida albicans.

Authors:  J L López-Ribot; W L Chaffin
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  A further insight into the mechanism of action of anthracycline antibiotics.

Authors:  G Palù; S Valisena; G Bertoloni; C Cera; M Palumbo
Journal:  Microbiologica       Date:  1988-10

10.  Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome.

Authors:  S V Komshian; A K Uwaydah; J D Sobel; L R Crane
Journal:  Rev Infect Dis       Date:  1989 May-Jun
View more
  2 in total

1.  Effect of thermal injury on the adherence of Candida albicans to murine splenic tissue.

Authors:  A N Neely; M M Orloff; I A Holder; D P Healy
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

2.  Adhesion of Candida albicans to brain tissue of Macaca mulata in an ex vivo assay.

Authors:  F J Denaro; J L López-Ribot; W L Chaffin
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.